A rare case of long-term paraesthesia diagnosed as a paraneoplastic syndrome by anti-SOX1 antibody determination.
Oriol MirallasNuria RialBerta Martín-CullellJesus Recio-IglesiasPublished in: BMJ case reports (2019)
Paraneoplastic syndromes (PS) are a rare presentation of cancer, most commonly associated with small cell lung cancer (SCLC), breast cancer and haematologic malignancies. The diagnosis of PS is challenging because it could affect multiple organ systems and it may present before the tumour is visible by imaging. We report a malignant tumour diagnosed in a male patient who referred long-term paraesthesia and proximal muscle strength loss. After ruling out common causes of polyneuropathy, the anti-SOX1 antibody gave light to the diagnosis. A pulmonary opacity in the upper right lobe was observed in the chest X-ray and a pulmonary tumour was later confirmed by CT scan. The biopsy of the cervical lymphadenopathy determined an SCLC, which caused a PS called Lambert-Eaton myasthenic syndrome (LEMS). Our case raises awareness of a rare PS presentation, which can be diagnosed by specific antibodies, allowing early diagnosis and treatment of lung cancer.
Keyphrases
- case report
- rare case
- small cell lung cancer
- dual energy
- computed tomography
- high resolution
- pulmonary hypertension
- transcription factor
- stem cells
- fine needle aspiration
- papillary thyroid
- ultrasound guided
- image quality
- squamous cell carcinoma
- squamous cell
- contrast enhanced
- young adults
- photodynamic therapy
- lymph node metastasis
- breast cancer risk